Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis

Pia Moinzadeh^*, Elisabeth Aberer, Keihan Ahmadi-Simab, Norbert Blank, Joerg H.W. Distler, Gerhard Fierlbeck, Ekkehard Genth, Claudia Guenther, Ruediger Hein, Joerg Henes, Lena Herich, Ilka Herrgott, Ina Koetter, Alexander Kreuter, Thomas Krieg, Kathrin Kuhr, Hanns Martin Lorenz, Florian Meier, Inga Melchers, Hartwig MensingUlf Mueller-Ladner, Christiane Pfeiffer, Gabriela Riemekasten, Miklós Sárdy, Marc Schmalzing, Cord Sunderkoetter, Laura Susok, Ingo H. Tarner, Peter Vaith, Margitta Worm, Gottfried Wozel, Gabriele Zeidler, Nicolas Hunzelmann

^*Corresponding author for this work

Clinic of Rheumatology

University of Cologne
Medizinische Universität Graz
Asklepios Klinik St. Georg
Ruprecht-Karls Universität Heidelberg
University of Erlangen–Nuremberg
University of Tubingen
Universitätsklinikum Carl Gustav Carus
Technical University of Munich
University of Münster
Robert Bosch GmbH
Helios St. Elisabeth Klinik Oberhausen
Kerckhoff Heart Center
University of Freiburg
University of Ulm
Ludwig-Maximilians-Universität
Ruhr-University Bochum
Humboldt University of Berlin

Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis

Fingerprint

Immunology and Microbiology

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology